倍氯米松/福莫特罗/格隆溴铵

倍氯米松/福莫特罗/格隆铵,以Trimbow等商品名销售,是一种用于治疗慢性阻塞性肺病(COPD)和哮喘的吸入式固定剂量复方药。它含有二丙酸倍氯米松延胡索酸福莫特罗二水合物格隆溴铵[3][4]

倍氯米松/福莫特罗/格隆溴铵
组成
二丙酸倍氯米松糖皮质激素
延胡索酸福莫特罗二水合物长效β2激动剂英语Long-acting beta-adrenoceptor agonist
格隆溴铵抗毒蕈碱剂英语Muscarinic antagonist
临床资料
商品名英语Drug nomenclatureTrimbow、Trydonis、Riarify等等
AHFS/Drugs.com英国药物信息
给药途径吸入
ATC码
法律规范状态
法律规范
识别信息
CAS号2447629-85-6

副作用包括口腔念珠菌症(由念珠菌引起的口腔真菌感染)、肌肉痉挛和口干。[3][4]

倍氯米松/福莫特罗/格隆铵于2017年7月和2018年4月在欧盟获准使用。[3][4][5]

参考资料

编辑
  1. ^ Trimbow ARTG ID 314166. Therapeutic Goods Administration (TGA). [21 July 2020]. [失效链接]
  2. ^ Trimbow 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution - Summary of Product Characteristics (SmPC). (emc). 8 February 2019 [5 March 2020]. (原始内容存档于2024-03-04). 
  3. ^ 3.0 3.1 3.2 Trimbow EPAR. European Medicines Agency (EMA). 5 March 2020 [5 March 2020]. (原始内容存档于2024-05-23).  Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  4. ^ 4.0 4.1 4.2 Trydonis EPAR. European Medicines Agency (EMA). 21 July 2020 [21 July 2020]. (原始内容存档于2024-03-06).  Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  5. ^ Riarify EPAR. European Medicines Agency (EMA). [21 July 2020]. (原始内容存档于2023-11-29). 

外部链接

编辑
  • Beclometasone dipropionate. Drug Information Portal. U.S. National Library of Medicine. [2023-12-08]. (原始内容存档于2022-10-02). 
  • Formoterol. Drug Information Portal. U.S. National Library of Medicine. [2023-12-08]. (原始内容存档于2021-03-31). 
  • Glycopyrronium bromide. Drug Information Portal. U.S. National Library of Medicine. [2023-12-08]. (原始内容存档于2020-02-29).